Melatonin prevents deterioration of erectile function in streptozotocin‐induced diabetic rats via sirtuin‐1 expression. (1st June 2020)
- Record Type:
- Journal Article
- Title:
- Melatonin prevents deterioration of erectile function in streptozotocin‐induced diabetic rats via sirtuin‐1 expression. (1st June 2020)
- Main Title:
- Melatonin prevents deterioration of erectile function in streptozotocin‐induced diabetic rats via sirtuin‐1 expression
- Authors:
- Sahan, Ahmet
Akbal, Cem
Tavukcu, Hasan Huseyin
Cevik, Ozge
Cetinel, Sule
Sekerci, Cagrı Akın
Sener, Tarik Emre
Sener, Goksel
Tanidir, Yiloren - Abstract:
- Abstract: A review of the literature indicated that sirtuin‐1 expression, a regulator of nitric oxide bioavailability in erectile dysfunction (ED) after melatonin therapy, has not yet been investigated. The objective of this study was to evaluate the protective effects of melatonin for erectile function with sirtuin‐1 protein expression in type 1 diabetic rat models. Fifty male Sprague Dawley rats were placed into five groups. Except for those in the control group (C), each animal received a single dose (60 mg/kg) of streptozotocin to induce diabetes. The animals were placed into the diabetes (D) group, insulin (I) group (6 U/kg/day), melatonin (Mel) group (10 mg kg −1 day −1 ) and combined treatment (I + Mel) group. Ten weeks later, the serum testosterone levels, intracavernosal pressure (ICP), mean arterial pressure (MAP), malondialdehyde (MDA), cyclic guanosine monophosphate (c‐GMP), 8‐hydroxydeoxyguanosine (8‐OHdG), nitric oxide synthase (NOS), caspase‐3 activity, sirtuin‐1 and endothelial nitric oxide synthase (eNOS) protein expression and histological findings were assessed. The mean ICP/MAP ratio for the D group was lower than the mean ratios for the other groups. The treatment groups, particularly the I + Mel group, exhibited lower 8‐OHdG and MDA levels and caspase‐3 activity than the D group. The sirtuin‐1 and eNOS expression and cavernosal tissue (CT) histology seemed to have been preserved by the melatonin and/or insulin therapy. These results were indicative ofAbstract: A review of the literature indicated that sirtuin‐1 expression, a regulator of nitric oxide bioavailability in erectile dysfunction (ED) after melatonin therapy, has not yet been investigated. The objective of this study was to evaluate the protective effects of melatonin for erectile function with sirtuin‐1 protein expression in type 1 diabetic rat models. Fifty male Sprague Dawley rats were placed into five groups. Except for those in the control group (C), each animal received a single dose (60 mg/kg) of streptozotocin to induce diabetes. The animals were placed into the diabetes (D) group, insulin (I) group (6 U/kg/day), melatonin (Mel) group (10 mg kg −1 day −1 ) and combined treatment (I + Mel) group. Ten weeks later, the serum testosterone levels, intracavernosal pressure (ICP), mean arterial pressure (MAP), malondialdehyde (MDA), cyclic guanosine monophosphate (c‐GMP), 8‐hydroxydeoxyguanosine (8‐OHdG), nitric oxide synthase (NOS), caspase‐3 activity, sirtuin‐1 and endothelial nitric oxide synthase (eNOS) protein expression and histological findings were assessed. The mean ICP/MAP ratio for the D group was lower than the mean ratios for the other groups. The treatment groups, particularly the I + Mel group, exhibited lower 8‐OHdG and MDA levels and caspase‐3 activity than the D group. The sirtuin‐1 and eNOS expression and cavernosal tissue (CT) histology seemed to have been preserved by the melatonin and/or insulin therapy. These results were indicative of a profound protective effect of melatonin by the activation of sirtuin‐1 protein expression against hyperglycemia‐induced oxidative CT injury. … (more)
- Is Part Of:
- Andrologia. Volume 52:Number 9(2020)
- Journal:
- Andrologia
- Issue:
- Volume 52:Number 9(2020)
- Issue Display:
- Volume 52, Issue 9 (2020)
- Year:
- 2020
- Volume:
- 52
- Issue:
- 9
- Issue Sort Value:
- 2020-0052-0009-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2020-06-01
- Subjects:
- antioxidant -- erectile dysfunction -- melatonin -- sirtuin 1 -- streptozotocin -- type 1 diabetes mellitus
Andrology -- Periodicals
Infertility, Male -- Periodicals
616.69 - Journal URLs:
- https://onlinelibrary.wiley.com/journal/14390272 ↗
https://www.hindawi.com/journals/and/ ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/and.13639 ↗
- Languages:
- English
- ISSNs:
- 0303-4569
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0900.443000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 14356.xml